Type
. The nasal discharge in leprosy. The Nursing journal of India. 1974;65(1):20.
Type
. Potential antileprotic agents. 2. Inhibition of mycobacterial dihydrofolic reductase. Journal of medicinal chemistry. 1974;17(1):144-6.
Type
. Potential antileprotic agents. 1. Inhibition of a model mycobacterial system by diaryl sulfones. Journal of medicinal chemistry. 1974;17(1):142-4.
Type
. Lepra cells in synovial fluid of a patient with erythema nodosum leprosum. The New England journal of medicine. 1973;289(26):1410-1.
Type
. Analogy of Mycobacterium marinum disease to Mycobacterium leprae infection in footpads of mice. Infection and immunity. 1973;8(6):860-7.
Type
. The significance of the fluorescent treponemal antibody (FTA-ABS) test in collagen disorders and leprosy. Journal of clinical pathology. 1973;26(12):968-72.
Type
. Leprosy in the nine-banded armandillo. Zeitschrift fur Tropenmedizin und Parasitologie. 1973;24:Suppl 1:53-65.
Type
. [Initial clinical results using new, experimentally developed therapeutic forms in leprosy]. Zeitschrift fur Tropenmedizin und Parasitologie. 1973;24:Suppl 1:40-52.
Type
. Fundamental data, methods and goals of present research on the treatment of leprosy. Zeitschrift fur Tropenmedizin und Parasitologie. 1973;24:Suppl 1:17-25.
Type
. Assessment of the bacteriological effect of combined treatment with rifadin, sulfamethoxypyrazine, and isoniazide in lepromatous leprosy. Zeitschrift fur Tropenmedizin und Parasitologie. 1973;24:32-5.